EDGAR Filing Documents for 0001437749-10-000837

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001437749-10-000837

Filing Date

2010-03-30

Accepted

2010-03-30 07:07:38

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	novabay_10k-123109.htm	10-K	2544913
2	EXHIBIT 10.7	ex10-7.htm	EX-10.7	25190
3	EXHIBIT 10.14	ex10-14.htm	EX-10.14	26950
4	EXHIBIT 10.18	ex10-18.htm	EX-10.18	26157
5	EXHIBIT 10.19	ex10-19.htm	EX-10.19	18119
6	EXHIBIT 10.20	ex10-20.htm	EX-10.20	68847
7	EXHIBIT 10.22	ex10-22.htm	EX-10.22	73166
8	EXHIBIT 23.1	ex23-1.htm	EX-23.1	3885
9	EXHIBIT 31.1	ex31-1.htm	EX-31.1	10090
10	EXHIBIT 31.2	ex31-2.htm	EX-31.2	10106
11	EXHIBIT 32.1	ex32-1.htm	EX-32.1	5249
12	EXHIBIT 32.2	ex32-2.htm	EX-32.2	5173
13		graph.jpg	GRAPHIC	63001
	Complete submission text file	0001437749-10-000837.txt		2906222

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608

Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800

NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)